Aspiration Technique-based Device for Preterm Labor (PREGNOLIA)
Primary Purpose
Preterm Labor, Preterm Birth
Status
Recruiting
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
PREGNOLIA SYSTEM
Sponsored by
About this trial
This is an interventional prevention trial for Preterm Labor
Eligibility Criteria
Inclusion Criteria:
- Singleton gestations with symptoms of preterm labor
- Gestational age between 24 and 33 weeks
- Maternal age ≥18 years
Exclusion Criteria:
- Cervical dilatation ≥ 3 cm;
- Rupture of membranes;
- Cerclage or pessary in place;
- Severe vaginal bleeding;
Sites / Locations
- Gabriele SacconeRecruiting
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
PREGNOLIA TEST
Arm Description
Women at the time of triage will be tested with TVU CL (transvaginal ultrasound cervical length) and with the PREGNOLIA system
Outcomes
Primary Outcome Measures
Value of the system in women with symptoms of preterm labor
detection rate of PREGNOLIA system in women with symptoms of preterm labor (sensitivity, specificity, detection rate).
Secondary Outcome Measures
Birth outcomes
Correlation between the system of the results and birth outcome (gestational age at birth, time to delivery, mode of delivery)
Comparison between pregnolia system and cevical length
Detection rate of the two systems
the change of the calcaneus stiffness index (CSI) at triage and discharge
to determine the change of the CSI at triage and discharge
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT05355649
Brief Title
Aspiration Technique-based Device for Preterm Labor
Acronym
PREGNOLIA
Official Title
Impact of a New Aspiration Technique-based Device for Assessment of Cervical Stiffness in Pregnant Women With Symptoms of Preterm Labour
Study Type
Interventional
2. Study Status
Record Verification Date
April 2022
Overall Recruitment Status
Recruiting
Study Start Date
April 8, 2022 (Actual)
Primary Completion Date
September 1, 2022 (Anticipated)
Study Completion Date
December 1, 2022 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Federico II University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Premature birth (PTB, birth before 37 weeks of pregnancy) is a global, yet unsolved, problem. With a global amount of approximately 15 M babies born prematurely, PTB is the leading cause of perinatal morbidity and mortality in many countries. Furthermore, premature babies often have complicated medical problems, especially those born very early.
Some women spontaneously deliver prematurely without any symptom or sign of the imminent labor, whereas others present with symptoms of preterm labor (PTL). In the latter case, clinicians can intervene and treat the woman with tocolytics and antenatal corticosteroids in order to accelerate fetal lung maturation and reduce the risk of respiratory distress syndrome. However, one of the major challenges in the management of women presenting with symptoms of PTL is to distinguish between true and false PTL with the existing clinical methods (digital examination or transvaginal cervical length assessment). In fact, over 50% of the women presenting with PTL symptoms do not deliver prematurely and are still unnecessarily hospitalized and treated with corticosteroids as well as tocolytics, and only less than 10% of women give birth within 7 days of presentation. Unnecessary treatments and hospitalizations also result in increased health costs.
Thus, there is a need for more accurate methods and tools to evaluate the cervical maturation status as indication of imminent labor in order to avoid unnecessary hospital admissions and therapy.
Recently, cervical stiffness has been evaluated as more reliable tool for prediction of spontaneous preterm birth. Cervical stiffness can be evaluated using ultrasound by cervical elastography , but also by an aspiration technique-based method with a novel CE-marked device, the Pregnolia System.
Thus, the aims of this study are to evaluate:
if the cervical stiffness measured with the Pregnolia System can differentiate between women with true PTL and those with false PTL,
if the knowledge of cervical stiffness improves the detection of women at true risk of spontaneous preterm birth in combination or over state of the art (e.g. cervical length on TVUS).
Detailed Description
Premature birth (PTB, birth before 37 weeks of pregnancy) is a global, yet unsolved, problem. With a global amount of approximately 15 M babies born prematurely, PTB is the leading cause of perinatal morbidity and mortality in many countries. Furthermore, premature babies often have complicated medical problems, especially those born very early.
Some women spontaneously deliver prematurely without any symptom or sign of the imminent labor, whereas others present with symptoms of preterm labor (PTL). In the latter case, clinicians can intervene and treat the woman with tocolytics and antenatal corticosteroids in order to accelerate fetal lung maturation and reduce the risk of respiratory distress syndrome. However, one of the major challenges in the management of women presenting with symptoms of PTL is to distinguish between true and false PTL with the existing clinical methods (digital examination or transvaginal cervical length assessment). In fact, over 50% of the women presenting with PTL symptoms do not deliver prematurely and are still unnecessarily hospitalized and treated with corticosteroids as well as tocolytics, and only less than 10% of women give birth within 7 days of presentation. Unnecessary treatments and hospitalizations also result in increased health costs.
Thus, there is a need for more accurate methods and tools to evaluate the cervical maturation status as indication of imminent labor in order to avoid unnecessary hospital admissions and therapy.
Recently, cervical stiffness has been evaluated as more reliable tool for prediction of spontaneous preterm birth. Cervical stiffness can be evaluated using ultrasound by cervical elastography , but also by an aspiration technique-based method with a novel CE-marked device, the Pregnolia System.
Thus, the aims of this study are to evaluate:
if the cervical stiffness measured with the Pregnolia System can differentiate between women with true PTL and those with false PTL,
if the knowledge of cervical stiffness improves the detection of women at true risk of spontaneous preterm birth in combination or over state of the art (e.g. cervical length on TVUS).
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Preterm Labor, Preterm Birth
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
PREGNOLIA SYSTEM
Masking
None (Open Label)
Allocation
N/A
Enrollment
100 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
PREGNOLIA TEST
Arm Type
Other
Arm Description
Women at the time of triage will be tested with TVU CL (transvaginal ultrasound cervical length) and with the PREGNOLIA system
Intervention Type
Device
Intervention Name(s)
PREGNOLIA SYSTEM
Intervention Description
The Pregnolia System is composed of two products: an active device (Pregnolia Control Unit) and a single-use sterile probe (Pregnolia Probe).
The intended use of the Pregnolia System is to provide information about the mechanical properties of the uterine cervix by assessing the tissue stiffness through a proxy parameter (the closing pressure, denominated CSI, or Cervical Stiffness Index, in mbar). The Pregnolia System is intended to be used in conjunction with the information obtained from the clinical evaluation of the patient and in addition to other standard examinations.
Primary Outcome Measure Information:
Title
Value of the system in women with symptoms of preterm labor
Description
detection rate of PREGNOLIA system in women with symptoms of preterm labor (sensitivity, specificity, detection rate).
Time Frame
up to 34 weeks
Secondary Outcome Measure Information:
Title
Birth outcomes
Description
Correlation between the system of the results and birth outcome (gestational age at birth, time to delivery, mode of delivery)
Time Frame
up to 34 weeks
Title
Comparison between pregnolia system and cevical length
Description
Detection rate of the two systems
Time Frame
up to 34 weeks
Title
the change of the calcaneus stiffness index (CSI) at triage and discharge
Description
to determine the change of the CSI at triage and discharge
Time Frame
up to 34 weeks
10. Eligibility
Sex
Female
Gender Based
Yes
Gender Eligibility Description
pregnant women
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Singleton gestations with symptoms of preterm labor
Gestational age between 24 and 33 weeks
Maternal age ≥18 years
Exclusion Criteria:
Cervical dilatation ≥ 3 cm;
Rupture of membranes;
Cerclage or pessary in place;
Severe vaginal bleeding;
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Gabriele Saccone, md
Phone
0817461111
Email
gabriele.saccone.1990@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Gabriele Saccone, md
Organizational Affiliation
federico ii
Official's Role
Principal Investigator
Facility Information:
Facility Name
Gabriele Saccone
City
Naples
ZIP/Postal Code
80100
Country
Italy
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Gabriele Saccone
Phone
0817461111
Email
gabriele.saccone.1990@gmail.com
12. IPD Sharing Statement
Plan to Share IPD
Undecided
IPD Sharing Plan Description
not planned yet
Learn more about this trial
Aspiration Technique-based Device for Preterm Labor
We'll reach out to this number within 24 hrs